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Introduction 
DNA methylation, along with histone modification, is a major component of 
epigenetic regulation, and is found in many organisms from bacteria to mammals. N6-
methyladenine, N4-methylcytosine and C5-methylcytosine are natural components of the 
DNA, since the addition of the methyl group does not interfere with the Watson-Crick pairing 
properties of the bases, but it provides new information for DNA-interacting proteins. 
In the genomes of eukaryotes only cytosine-C5 methylation can be found, which in 
mammals occurs mainly at CpG sequences. Cytosine methylation is catalyzed by DNA-
cytosine methyltransferases, which transfer an activated methyl group from the donor S-
adenosyl-L-methionine (SAM) to the carbon-5 of the cytosine. The genomic distribution of 
the methylcytosine residues is not random, it rather forms a tissue specific pattern. Properly 
established and maintained methylation patterns are essential for mammalian development 
and for appropriate function of the organism. Abnormal methylation can be linked to aging 
and to a number of pathological conditions, such as neurodegenerative diseases, diabetes or 
cancer. Epigenetic research focusing on DNA-methylation is of great importance not only in 
diagnostics but in the development of potential therapies as well. Thus there are on-going 
research efforts to study the methylation profile of selected genes and correlate it with tissue-
specific gene expression in health and disease. The most widely used method for 
identification of methylated cytosines employs the treatment of genomic DNA with sodium-
bisulfite. Upon this treatment unmethylated cytosines deaminate to uracil through the 
formation of an unstable dihydro-cytosine residue, while 5-methylcytosines remain 
unchanged. Due to the conditions used to achieve complete conversion (long incubation of 
single stranded DNA at high temperature and low pH) the method is prone to certain reaction 
artefacts that affect its reliability. 
 It was observed that certain prokaryotic DNA-methyltransferases and the catalytic 
domain of the mammalian Dnmt3a MTase are able to catalyse deamination of the target 
cytosine to uracil if the methyl donor SAM is omitted from the reaction. The enzymatic 
cytosine deamination is assumed to follow a path analogous to that of bisulfite mediated C-to-
T conversion and is based on the formation of 5,6-dihydro-cytosine intermediate generated 
during the methyl-transfer. The prokaryotic DNA-(cytosine-5)-methyltransferase SssI shares 
the specificity of eukaryotic DNA methyltransferases (CG), and is an important model and 
experimental tool in the study of eukaryotic DNA methylation. Results in the literature on the 
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deaminase ability of this enzyme are controversial. Some results showed that M.SssI can 
deaminate cytosine or even 
m5
C, whereas another study did not find evidence for M.SssI-
mediated cytosine deamination. 
 
Aims of the study 
 Based on the similarity of the bisulfite mediated and enzymatic cytosine deamination, 
we intended to explore the possibility of using the deamination side-activity of the M.SssI to 
distinguish between unmethylated and C5-methylated cytosines in the epigenetically relevant 
CpG dinucleotides. The use of M.SssI as an enzymatic alternative to bisulfite conversion 
would allow bypassing some of the technical difficulties associated with this method. We 
wished to address the following specific questions: 
 Can the SssI methyltransferase catalyse deamination of cytosine? This question was 
justified because of the conflicting data in the literature on this matter.  
 Can the SssI methyltransferase catalyse deamination of 5-methylcytosine? 
 Can we find reaction conditions where the rate difference between M.SssI catalyzed 
cytosine and 5-methylcytosine deamination is sufficient for reliable discrimination 
between cytosine and 5-methylcytosine? 
 Can we create conditions where the SssI MTase shows deamination activity in vivo, in 
the presence of SAM? 
 
 In the course of our work with the SssI DNA methyltransferase an accidental 
observation led to the discovery that CG-specific methylation creates new substrate sites for 
the MvaI restriction enzyme. These new sites differed from the known CCWGG (W can be A 
or T) MvaI recognition sequence, therefore we set out to characterise the new, methylation-
dependent substrate sites and cleavage. This work shed light on a previously unknown activity 
of the MvaI endonuclease. 
 
 
3 
 
 
Methods 
 Recombinant DNA techniques, creation of plasmid constructs 
 Site directed mutagenesis, creation of protein variants with amino acid substitutions 
 Western blot analysis and affinity chromatography  
 In vivo and in vitro methyltransferase activity assay 
 Mutation rate measurements 
 DNA sequence analysis 
 Radioactive labelling of oligonucleotides and phosphor-image analysis 
 Statistical evaluation of experimental data 
 
 
Results 
 To detect the C-to-U deamination by M.SssI, we used a sensitive genetic assay based 
on the reversion to wild-type of the antibiotic sensitive phenotype determined by a mutant 
kanamycin resistance gene. The pUP41 plasmid carries a mutant kanamycin resistance gene 
in which an amino acid substitution led to kanamycin sensitive phenotype. The mutant codon 
is located within a SmaI restriction site CCCGGG. Conversion of the underlined cytosine to 
thymine reverts the amino acid substitution to wild-type and restores kanamycin resistance. 
Because the underlined cytosine is in a CG dinucleotide, the substrate site for SssI DNA 
methyltransferase, pUP41 can be used to assay M.SssI-catalyzed cytosine deamination. 
Deamination of cytosine first creates a U:G mismatch, which – if left unrepaired – is 
converted to C-to-T mutation after DNA replication. Reversion to kanamycin resistance by 
cytosine deamination as described above eliminates the SmaI site and creates a new MvaI site 
(CCWGG). 
Confirming some of the previous results we could show that M.SssI can deaminate 
cytosines to uracil in a slow reaction, and that the rate of the conversion can be increased by 
the SAM analogue 5’-amino-5’-deoxyadenosine (AA).  
In single-stranded DNA the rate of bisulfite mediated conversion of C-to-U is ~50-fold 
higher than the rate of 
m5
C-to-T conversion, which forms the basis of bisulfite-sequencing. 
We compared the reactivities of cytosine and 5-methylcytosine to M.SssI mediated 
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deamination in double stranded DNA, and found that in the presence of AA the difference of 
the reaction rates is at least 100-fold. This suggests that the M.SssI-catalysed conversion is 
sensitive enough to reliably discriminate between unmethylated and C5-methylated cytosines. 
However, our results showed that the rate of M.SssI mediated cytosine deamination is still 
much slower than that obtained with standard bisulfite protocols, making the M.SssI mediated 
cytosine deamination, at present, impractical as an alternative to bisulfite sequencing. 
Besides studying this side activity of M.SssI in vitro, we wished to test whether the 
enzyme can be used to deaminate cytosines in vivo, in the presence of SAM. To this end we 
constructed two mutant enzymes using information from previous work with the HpaII 
MTase. Amino acids Phe17 and Gly19 of conserved motif I, presumed to be part of the SAM 
binding pocket, were changed by site directed mutagenesis to Ser and Asp respectively. We 
expected the amino acid substitutions to weaken the cofactor binding abilities of the enzyme, 
and thus to mimic conditions of limiting SAM in vivo. The cytosine deamination activity of 
both mutant enzymes (F17S and G19D) was tested in two different E. coli hosts. In one of 
them the sssIM allele and the targeted mutant kanamycin gene (kanS) gene were on two 
separate plasmids, while the other host carried the kanS gene on the chromosome. The G19D 
variant caused a ~10-fold increase in the deamination rate in both types of hosts lacking 
uracil-DNA-glycosylase (Ung) related repair, while the WT enzyme and the F17S mutant had 
no effect. The elevated C-to-U reversion rate was also demonstrated by fluctuation test. 
Interestingly, M.SssI(G19D) increased the deamination rate also in Ung
+ 
hosts, suggesting 
that the enzyme can block uracil-DNA glycosylase mediated repair. Consistent with the 
envisioned effect of impaired SAM binding, both mutants had reduced methyltransferase 
activities in vivo and in vitro compared to WT.  
During our work with the CG-specific DNA cytosine-5 methyltransferase M.SssI, we 
noticed that in vivo or in vitro M.SssI methylation leads to the appearance of new substrate 
sites for the MvaI restriction enzyme. Appearance of these new sites was dependent on CG-
methylation and was specific for MvaI, the phenomenon was not shown by its isoschizomer 
BstNI. 
 The MvaI restriction endonuclease cuts the CC↓AGG/CC↑TGG double-stranded 
sequence, as indicated by the arrows, as a monomer. The cognate MvaI MTase modifies the 
internal cytosine to produce N4-methylcytosine (C
m4
CAGG/C
m4
CTGG). C5-methylation of 
the same cytosine does not protect the site against MvaI cleavage. We have shown that the 
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MvaI endonuclease, in addition to its double-stranded cleavage activity on the canonical 
recognition sequence CC↓AGG/CC↑TGG, nicks BcnI sites (Cm5C↓GGG/CCm5CGG) as 
indicated, if the inner cytosines are C5-methylated. This nicking activity results in double-
strand scissions at CC
m5
C↓GGG/CCm5C↑GGG (CG-methylated SmaI) sites, where two 
oppositely oriented methylated BcnI sites overlap. The double-stranded cleavage rate and the 
stringency of the substrate site recognition are lower at the methylation-dependent site than at 
the canonical target sites.  
MvaI formally combines features of “typical” Type II REases cutting unmethylated 
sequences, with those of methyl-directed Type II enzymes, which require methylated 
substrate sites. To our knowledge, MvaI is the first REase, for which such dual specificity has 
been shown. The new, methylation-dependent activity represents nicking and double-stranded 
cleavage specificities (C
m5C↓GGG/CCm5CGG and CCm5C↓GGG/CCm5C↑GGG, respectively) 
not known before. 
 
 
Results in brief 
 
 We have shown that in the absence of the methyldonor (SAM) M.SssI can catalyze the 
deamination of cytosines in CG dinucleotides and the rate of this reaction can be 
increased by the SAM analogue 5'-amino-5'-deoxyadenosine.  
 
 We have shown that similarly to the bisulfite mediated conversion, cytosine and 5-
methylcytosine have different reactivities to the M.SssI catalyzed deamination. 
 
 Our results show that the slow rate of the enzyme catalyzed cytosine deamination 
reaction makes the M.SssI in its present form impractical to be used as an alternative 
to bisulfite conversion. Nevertheless, the E. coli-KanS strain constructed during this 
study offers a directed evolution strategy to select M.SssI variants with increased 
cytosine deaminase activity. 
 
 We have shown that the amino acid substitutions F17S and G19D lead to severe drop 
in the methyltransferase activity and the G19D mutant enzyme has enhanced C-to-U 
deaminase activity in vivo, where SAM is present. This result raises the possibility of 
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using the enzyme variant as a CG-specific targetable cytosine deaminase to induce C-
to-T transitions at pre-determined CG sites in vivo. 
 
 We have shown that the MvaI endonuclease has dual specificity: in addition to its 
double-stranded activity on the canonical recognition site, it is able to nick another 
specifically methylated sequence. This inherent property of the MvaI restriction 
enzyme must be taken into consideration when working with CG-specifically 
methylated DNA e.g. digestion of mammalian DNA. The methyl-directed activity of 
the enzyme represents new cleavage specificity, broadening the toolbar of DNA-
research. 
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